Mutation in the isocitrate dehydrogenase gene (IDH) and co-deletion of chromosome 1p and 19q (1p/19q co-deletion) in low-grade gliomas (grade I and II) are associated with favorable prognosis [16,17]. The gene discussed is IDH1; the disease is central nervous system cancer.